Podovia Sp. z o.o.
- Address
- Ul. Starolecka 42c, 61-361 Poznan, Poland
Podovia Sp. z o.o. - Infectious Disease Research Center
Podovia Sp. z o.o. is a specialized clinical research facility focused on advancing treatments for complex infectious diseases. The center demonstrates particular expertise in evaluating novel antimicrobial therapies for challenging bacterial infections in vulnerable patient populations.
- Diabetic foot infections and their management in moderate to severe cases
- Comparative effectiveness studies of advanced antibiotic therapies
- Phase 3 randomized controlled trials evaluating safety and efficacy of investigational antimicrobials
The research team at Podovia specializes in conducting rigorous double-blind, multicenter trials that compare novel therapeutic agents such as contezolid acefosamil against established treatments like linezolid. Their clinical investigations employ comprehensive assessment methodologies, including both intravenous and oral administration routes, to evaluate clinical response, safety, and tolerability profiles. This integrated approach to antimicrobial research positions Podovia as a key contributor to developing improved treatment options for patients suffering from serious diabetic complications and related infectious disease conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Podovia Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Topical Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers Infected by Acinetobacter baumannii, Pseudomonas aeruginosa, or Staphylococcus aureus | Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A. | Phase II | Not Recruiting | — | Dec 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| F1245/05 | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.